Αποτελέσματα Αναζήτησης
16 Ιουλ 2021 · These guidelines bring in the most recent guidance on HIV testing strategies - the entry point for HIV prevention and treatment - and include comprehensive guidance on infant diagnosis. Key recommendations are presented on rapid antiretroviral therapy (ART) initiation and the use of dolutegravir.
- HIV Testing
Testing and diagnostics are critical components of the...
- HIV and AIDS
New technologies are now available to perform this test at...
- HIV Testing
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
11 Δεκ 2023 · Using drug therapy to block transmission and prevent HIV, HIV pre-exposure prophylaxis (PrEP) provides a critical intervention to reduce community spread and protect those with reasons to utilize PrEP.
2 Ιουν 2021 · Initial testing for HIV should be performed with a Food and Drug Administration–approved antigen–antibody immunoassay that detects HIV type 1 (HIV-1) and HIV type 2 (HIV-2) antibodies and HIV ...
Preexposure prophylaxis (PrEP), the use of highly effective antiretroviral drugs to prevent HIV, is a key component of the Ending the HIV Epidemic Initiative in the US that aims to reduce new HIV cases by 90% by 2030.
Persons with a new diagnosis of HIV infection should be promptly referred to a clinical setting where a full HIV assessment can be performed and antiretroviral therapy can be initiated rapidly.
27 Φεβ 2024 · Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV i . Table of Contents . What’s New in the Guidelines ..... vi. Panel Roster ..... vii. i
